Joanna Poutou
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
Journal: Nature biomedical engineering
Published: March 25, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.
Journal: Nature communications
Published: October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
Journal: Molecular therapy. Methods & clinical development
Published: May 02, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 20, 2023
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment.
Journal: Frontiers in immunology
Published: November 15, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter.
Journal: Journal of visualized experiments : JoVE
Published: August 30, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 30, 2021
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection.
Journal: Journal of visualized experiments : JoVE
Published: June 21, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Journal: International journal of molecular sciences
Published: February 02, 2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion.
Journal: Nanomaterials (Basel, Switzerland)
Published: December 22, 2020
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 17, 2020
Last Updated: 09/26/2026